Get started
Author

Lukas Dillinger

Observed names: L Dillinger, L. Dillinger
OpenAlex ID: A5022827775
Dysregulated stem cell niches and altered lymphocyte recirculation cause B and T cell lymphopenia in WHIM syndrome
2022 · Sandra Zehentmeier, Vivian Y. Lim, et al. · Science Immunology · 25
In vitro potency and pharmacokinetics of APG777, a novel anti–IL-13 mAb
2025 · Eric Zhu, Holly Prentice, et al. · Journal of Allergy and Clinical Immunology Global · 3
Apg777, Anti-il-13 Monoclonal Antibody, Demonstrates Extended Half-life and Sustained Inhibition of Type 2 Inflammatory Biomarkers
2024 · X. Lim, E. Winter, et al. · Annals of Allergy Asthma & Immunology · 3
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19
2022 · Elizabeth E. Zumbrun, Chengzi I. Kaku, et al. · Antimicrobial Agents and Chemotherapy · 2
The Combination of APG777 (anti-IL-13) and APG333 (anti-TSLP) Inhibits Central and Local Drivers of Obstructive Airway Disease
2025 · K. Barth, G. Wickman, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Preclinical Potency, Affinity, and Pharmacokinetics of APG990, a Half-Life Extended Antibody Against OX40L
2025 · Grant Wickman, Byong Ha Kang, et al. · SKIN The Journal of Cutaneous Medicine · 1
Zumilokibart (APG777), a half-life extended monoclonal antibody, improves IL-13–driven airway pathology in preclinical asthma models
2026 · Kristie Barth, Kimberly Barker, et al. · European Respiratory Journal
0517 Zumilokibart (APG777), a half-life-extended monoclonal antibody, provides rapid and sustained inhibition of type 2 biomarkers in moderate-to-severe atopic dermatitis
2026 · E. Guttman-Yassky, M. Gooderham, et al. · Journal of Investigative Dermatology
0553 Zumilokibart (APG777) induces rapid and robust normalization of the lesional and non-lesional atopic dermatitis skin phenotype
2026 · J. Fiedler, J. Zhou, et al. · Journal of Investigative Dermatology
PDF
CXCR4 antagonism restores dendritic cell migration and activation in a WHIM syndrome mouse model
2026 · Alexie Ouchakoff, Mathilde Puel, et al. · bioRxiv (Cold Spring Harbor Laboratory)
220 A Combination of APG777 (anti-IL-13) and APG990 (anti-OX40L) Improves Inflammatory and Barrier Disruption Pathologies of Atopic Dermatitis
2025 · Brittany Mihelich, Kristie Barth, et al. · Journal of Investigative Dermatology
PDF
264 APG777, a half-life-extended mAb targeting IL-13, demonstrates rapid and sustained inhibition of serum TARC levels in patients with moderate to severe atopic dermatitis
2025 · Emma Guttman-Yassky, Sai Thankamony, et al. · Journal of Investigative Dermatology
PDF
62478 The Combination of APG777 (Anti-IL-13) and APG990 (Anti-OX40L) Provides Broad Suppression of Inflammatory Cytokines
2025 · Grant Wickman, Kristie Barth, et al. · Journal of the American Academy of Dermatology
The Combination of APG777 (anti-IL-13) and APG333 (anti-TSLP) Improves Type 2 Inflammatory Suppression Compared to Single Agents
2025 · Kristie Barth, Grant Wickman, et al. · Journal of Allergy and Clinical Immunology
Preclinical and Pharmacokinetic Characterization of APG333: A Fully Human Monoclonal Antibody that Binds TSLP with High Affinity and Potently Inhibits Downstream Signaling
2025 · Jessica Meinke, Jacob Milligan, et al. · Journal of Allergy and Clinical Immunology
PDF
711 - Prolonged half-life and sustained inhibition of key inflammatory biomarkers: a phase 1 study of APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13
2024 · Xiu Qin Lim, Erica Winter, et al. · British Journal of Dermatology
758 APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13, demonstrates prolonged half-life and pSTAT6 inhibition in non-human primates
2024 · E. Zhu, J. Oh, et al. · Journal of Investigative Dermatology
LB945 Prolonged half-life and sustained inhibition of key inflammatory biomarkers: a phase 1 study of APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13
2024 · X.Q. Lim, E. Winter, et al. · Journal of Investigative Dermatology
PDF
APG808, A Fully Human Monoclonal IgG1 Antibody, Binds to IL-4Rα With High Affinity and Blocks IL-13 and IL-4 Mediated Signalling in Multiple In Vitro Assays
2024 · L. Dillinger, R. Dabora, et al. · American Journal of Respiratory and Critical Care Medicine
APG808, A High-Affinity Fully Human IgG1 Monoclonal Antibody Targeting IL-4Rα, Demonstrates Prolonged Half-Life in Non-Human Primates
2024 · L. Dillinger, R. Dabora, et al. · American Journal of Respiratory and Critical Care Medicine
Abstract 6093: Mavorixafor enhances efficacy of Bruton tyrosine kinase inhibitors by overcoming the protective effect of bone marrow stroma on tumor cells in Waldenström’s macroglobulinemia
2022 · Chi Nguyen, Halenya Monticelli, et al. · Cancer Research
AB1108 Handling of de novo arthritis in adults by general practitioners: a survey in a french cohort
2017 · S Lecauchois, S Gentile, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 22
Citation count: 35
H-index: 3
I10-index: 1
Year
Topic
Type